SCHEMBL9979036

SCHEMBL9979036

CCCCCCC(CC(=O)O)(C(=O)OCC)S(=O)(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 1/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
HTT P42858 1/20 0.39
THRB P10828 1/20 0.36
PKM P14618 1/20 0.36
TDP1 Q9NUW8 3/20 0.36
FFAR1 O14842 2/20 0.36
CPT2 P23786 1/20 0.36
PAM P19021 2/20 0.35
PPARG P37231 5/20 0.34
PPARD Q03181 5/20 0.34
PPARA Q07869 5/20 0.34
HDAC11 Q96DB2 4/20 0.34
TSHR P16473 3/20 0.34
GPR84 Q9NQS5 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9296921 0.90 NAAA (0.37) MEN1KMT2AMAPTATML3MBTL1
SCHEMBL454014 0.90 NAAA (0.40) TSHR
SCHEMBL3806159 0.90 NAAA (0.40) TSHR
SCHEMBL10776305 0.90 NAAA (0.40) TSHR
SCHEMBL1413235 0.90 NAAA (0.40) TSHR
SCHEMBL7778396 0.90 NAAA (0.40) TSHR
SCHEMBL9437676 0.90 NAAA (0.40) TSHR
SCHEMBL28328189 0.90 NAAA (0.40) TSHR
SCHEMBL6544578 0.90 NAAA (0.40) TSHR
SCHEMBL28773471 0.89 NAAA (0.39) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630057-B1 PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS CHANEL PARFUMS BEAUTE (FR) 2021-08-18 EP claimed
EP-3463585-B1 PERFUMES IN THE FORM OF AQUEOUS MICROEMULSIONS CHANEL PARFUMS BEAUTE (FR) 2020-07-08 EP claimed
US-20220054377-A1 CHEMICAL PROCESS TO TRANSFORM BODY ODOR OSTER AIDAN WILLIAM (US) 2022-02-24 US disclosed
US-20130203825-A1 PHOSPHATE-FREE HIGHLY CONCENTRATED AQUEOUS DISPERSION COMPOSITION OF BIOCIDES AND PROCESS FOR PREPARING THE SAME ISP INVESTMENTS INC. (US) 2013-08-08 US disclosed
WO-2011150224-A1 A PHOSPHATE-FREE HIGHLY CONCENTRATED AQUEOUS DISPERSION COMPOSITION OF BIOCIDES AND PROCESS FOR PREPARING THE SAME ISP INVESTMENTS INC. (US) 2011-12-01 WO disclosed
US-4857148-A Staple fiber, finish therefor and process for use of same HOECHST FIBERS INDUSTRIES (US) 1989-08-15 US disclosed
US-4294883-A EMULSIFIERS, LUBRICANTS, ANIONIC SURFACTANTS HOECHST FIBERS INDUSTRIES, DIV. OF AMERICAN HOECHST CORPORATION (US) 1981-10-13 US disclosed
US-4191655-A Dewatering composition BETZ LABORATORIES, INC. (US) 1980-03-04 US disclosed
US-4156649-A Dewatering ore concentrates with branched alkyl ethoxylated alcohol BETZ LABORATORIES, INC. (US) 1979-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203825-A1 PHOSPHATE-FREE HIGHLY CONCENTRATED AQUEOUS DISPERSION COMPOSITION OF BIOCIDES AND PROCESS FOR PREPARING THE SAME SLC35B2, SLC39A3, MPST MEN1 3198/4885KMT2A 2386/4885MAPT 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.